TRPV3 and nonpapillary renal cell carcinoma: Conclusively, we developed a potential SNHG3/AL513497.1-miR-10b-5p-TRPV3 axis in the progress of ccRCC, which might provide effective prognostic biomarkers and promising treatment targets for ccRCC.